banner
Renin-angiotensin-aldosterone system (RAAS) inhibitor Olmesartan medoxomil, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ748

Renin-angiotensin-aldosterone system (RAAS) inhibitor Olmesartan medoxomil, Purity ≥98%

Synonym: 144689-63-4; Renin-angiotensin-aldosterone system (RAAS) inhibitor; Benicar; Olmetec

  • MDL: MFCD00944911
  • CAS Number: 144689-63-4
  • Compound CID: 130881
img
Product Size
25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Olmesartan medoxomil, soluble in DMSO and insoluble in ethanol and water, regulates blood pressure and fluid balance by blocking the effects of the RAAS pathway, which plays a critical role in the body’s cardiovascular health. It targets AT1 receptor.
Molecular Weight
558.6
Molecular Formula
C29H30N6O6
Targets
AT1 receptor
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 82 mg/mL (146.79 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Olmesartan medoxomil is investigated for its role in controlling blood pressure and treating related cardiovascular conditions.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0